Activation of the kinin-forming system during therapy with cyclophosphamide.
D001798:Blood Proteins / Q000032:analysis; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy*; D002277:Carcinoma / Q000097:blood / Q000188:drug therapy*; D002918:Chymotrypsin; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007704:Kininogens / Q000097:blood*; D007705:Kinins / Q000097:blood*; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors
D001798:Blood Proteins; D006454:Hemoglobins; D007704:Kininogens; D007705:Kinins; D003520:Cyclophosphamide; D002918:Chymotrypsin